Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI

XunZi, an AI biologist, reveals disease-modifying targets.

Xinhe Huang Junhong Qin Fei Tang Chen-Yu Yang Linhua Xu Junfen Wei Dan Liu Kang Chen Chi Zhang Miao-Miao Chen Yujie Gou Jiayi Zhang Yongze Ma Lin Zhao Ying-Feng Tu Peng Lei Yu Xue Da Jia
Aug 2026 · Nature Biomedical Engineering · 0 citations · 69 references
Medicine

TL;DR

In Parkinson's disease (PD), where complex mechanisms and limited targets hamper therapy development, XunZi identifies aberrant activation of CHK2 and IRAK4 kinases across multiple models and establishes a paradigm-shifting framework to translate fragmented biomedical knowledge and data into actionable therapeutics.

DOI PubMed Semantic Scholar
View source

Similar papers

Review Aug 2026

Neuropharmacology in the Era of Precision Medicine: From Synaptic Targets to Personalized Therapies.

Neuropsychiatric and neurodegenerative disorders show wide variability in treatment response, thus limiting the effectiveness of traditional symptom-based neuropharmacology. Precision medicine offers a more targeted approach by combining pharmacogenomics, multi-omics data, and artificial intelligence to guide individua...

L. al-Eitan · 0 citations
Review Open access Aug 2026

Multi‐omics–driven precision medicine

The value of MODPM lies not in stacking additional data layers but in building a multiscale, continuously learnable framework to link biological heterogeneity to clinically interpretable and actionable decisions.

Hui-Bo Li, Zhe Zhao, Yi-Fan Zhang et al. · 0 citations
Review Open access Aug 2026

AI-Guided Systems Neurogenomics in Neurodevelopmental Disorders

A hypothesis-generating load-capacity framework comprising regulatory load, network capacity, developmental buffering and regulatory network instability is proposed, and the Instability Twin is described as a prospective architecture composed of independently testable patient-specific sub-models rather than an existing...

H. Goel, T. Dudding-Byth, B. Kamien · 0 citations
Review Open access Sep 2026

Network biology to artificial intelligence: building the next generation of predictive drug discovery

Artificial intelligence-driven systems biology approaches could contribute to the development of dynamic, patient-specific computational representations of biological systems, potentially accelerating precision medicine and transforming drug discovery from empirical experimentation toward predictive, mechanism-guided t...

Kumar Selvarajoo · 0 citations
Review Open access Sep 2026

AI-guided ethnopharmacology for cardiovascular drug discovery: from biomedical data to experimental validation

Despite substantial advances in pharmacological therapy, cardiovascular disease remains the leading cause of mortality worldwide. Botanical drugs represent a rich source of structurally diverse bioactive metabolites, yet their translation into modern cardiovascular therapeutics remains limited by chemical complexity, i...

Shu-Xun Yao, Xiao-Xin Chen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.